Squeezing more production out of bacteria

September 21, 2010 by Anne Trafton
A scanning electron micrograph of E. coli. Credit: NIH

Engineering microorganisms to manufacture chemicals is not a new idea: In the 1980s, scientists figured out how to get bacteria to produce insulin, which diabetics need to control their disease. This technique, known as metabolic engineering, involves inserting many copies of the gene for a desired compound into bacteria or yeast cells. Scientists have also used this approach to turn bacteria into tiny factories that can generate biofuels such as ethanol, as well as plastics.

MIT chemical engineering professor Kristala Jones Prather and colleagues are now taking genetic manipulation a step further. By tinkering with the genes before inserting them into , they can manipulate each step of a synthetic reaction inside a cell. That strategy, known as , lets researchers use bacteria to make new products, or to boost production of naturally occurring compounds.

By combining protein engineering with traditional , Prather and her colleagues recently induced E. coli to synthesize a chemical normally secreted by plants, at a rate 2,600 times that of the natural reaction, and about four times greater than using traditional metabolic engineering alone. This approach could be applied to any kind of synthetic pathway inside a cell, including those that produce pharmaceutical compounds or biofuels, says Prather.

In a study recently published in the , Prather and postdoctoral associates Effendi Leonard and Ajikumar Parayil focused on a biological pathway that produces a class of compounds known as terpenoids. There are at least 60,000 known terpenoids, many of which are produced by plants and contribute to the distinctive flavors of cinnamon, cloves and ginger.

In plants, terpenoids serve as chemoattractants, enticing insects to pollinate them, or repelling predators. Of more interest to humans, terpenoids can be converted to ginkgolides, naturally produced by the ginkgo biloba plant. Ginkgolides have been associated with memory enhancement, though their effectiveness has not been proven. They are also being investigated for treatment of multiple sclerosis and vitiligo, a skin disorder.

Obtaining large quantities of terpenoids or gingkolides is difficult because plants don’t produce them in large quantities, and there is no way to synthesize them in a laboratory.

Targeting enzymes

The MIT team, which also included professors Gregory Stephanopoulos and Bruce Tidor, focused on a reaction pathway whose end product, levopimaradiene, is a terpenoid that can be converted to ginkgolides. Bacteria don’t normally produce levopimaradiene, so the researchers added genes for two plant enzymes that can convert chemicals found in bacteria into levopimaradiene. 

However, those enzymes don’t yield enough of the desired product, so the researchers started trying to redesign the enzymes to make them more efficient. They started with an enzyme called LPS, which catalyzes the last step of the process, converting a compound called GGPP to levopimaradiene. LPS can also convert GGPP to three other products, so the researchers tried to create a new version that would generate levopimaradiene exclusively.

To do this, they identified a stretch of 15 amino acids in the enzyme where altering the sequence should have the greatest effect, and tested about 120 proteins with different sequences. Using this very targeted approach, they found an enzyme variation that produces 97 percent levopimaradiene (compared to 85 percent for the original enzyme), and is about five times faster than the original.

Though highly successful, this approach only works when the researchers have a good structural model of the original protein, says Prather.

Next, the researchers tackled the second-to-last step of the process, which is the conversion of two compounds naturally found in bacteria to GGPP by an enzyme. For this step, they used a more traditional protein-engineering approach, creating about 1 million variants of the original protein, then testing their enzymatic efficiency. This less targeted approach usually works only if there is a way to rapidly test large numbers of proteins, which there was in this case. Their final enzyme was twice as fast as the original.

The researchers also gained a 600-fold boost in productivity by only using traditional metabolic engineering, adding extra copies of three genes for enzymes involved in earlier stages of terpenoid synthesis.  Combining protein engineering resulted in an overall levopimaradiene yield 2,600 times greater than that of the unengineered enzymes. In adding extra copies, the researchers have to be careful not to add too many, which can overwhelm the bacteria and actually slow down production.

Next, Prather plans to apply this strategy to other pathways, including one that produces hydroxy acids, which are useful for drug manufacturing. She has patented the mutant bacterial strains produced in the PNAS study, but is not planning to commercialize the process.

Claudia Schmidt-Dannert, associate professor of biochemistry at the University of Minnesota, says she believes this approach should prove useful in engineering many different types of metabolic pathways. “Just making these little improvements in bottleneck enzymes can have a big impact on the overall production of the pathway,” she says.

This story is republished courtesy of MIT News (web.mit.edu/newsoffice/), a popular site that covers news about MIT research, innovation and teaching.

Explore further: Periwinkle can serve as tiny chemical plant

Related Stories

Periwinkle can serve as tiny chemical plant

November 16, 2006

MIT researchers have discovered a way to manipulate the chemistry taking place in the tiny periwinkle plant to produce novel compounds that could have pharmacological benefits.

Important Plant Enzymes Identified

May 23, 2008

Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have identified enzymes important in the modification of isoflavonoids, natural plant products that help plants resist fungal infections, and may ...

Chemists engineer plants to produce new compounds

January 19, 2009

(PhysOrg.com) -- In work that could expand the frontiers of genetic engineering, MIT chemists have, for the first time, genetically altered a plant to produce entirely new compounds, some of which could be used as drugs against ...

Enzyme Trio for Biosynthesis of Hydrocarbon Fuels

June 21, 2010

(PhysOrg.com) -- Scientists with the Joint BioEnergy Institute have identified a trio of bacterial enzymes that can catalyze key steps in the conversion of plant sugars into hydrocarbon compounds for the production of green ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

New 'self-healing' gel makes electronics more flexible

November 25, 2015

Researchers in the Cockrell School of Engineering at The University of Texas at Austin have developed a first-of-its-kind self-healing gel that repairs and connects electronic circuits, creating opportunities to advance the ...

Getting under the skin of a medieval mystery

November 23, 2015

A simple PVC eraser has helped an international team of scientists led by bioarchaeologists at the University of York to resolve the mystery surrounding the tissue-thin parchment used by medieval scribes to produce the first ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.